Vimarsana
Biggest News Aggregation in the World

Page 32 - Regulated Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Regulated Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Regulated Information Today - Breaking & Trending Today

IPSOS: Monthly declaration of shares and voting rights - - Vimarsana News

IPSOS: Monthly declaration of shares and voting rights -

April 28, 2023 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the...

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ... - Vimarsana News

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ...

Regulated Information - Denominator

MIG: ANNOUNCEMENT OF REGULATED INFORMATION - Vimarsana News

MIG: ANNOUNCEMENT OF REGULATED INFORMATION

28/04/2023 ANNOUNCEMENT Disclosure of Regulated Information "MIG HOLDINGS S.A." hereby announces, in... | April 28, 2023

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS - Vimarsana News

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ATLAS

Regulated Information - Denominator Atlas Special Opportunities, LLC has converted 6 convertible bonds in Oxurion resulting in a EUR 150,000 capital increase. This is part of Atlas Special

ACTICOR BIOTECH: Availability of the 2022 Universal Registration Document and the preparatory documents for the combined general meeting of May 12, 2023 - Vimarsana News

ACTICOR BIOTECH: Availability of the 2022 Universal Registration Document and the preparatory documents for the combined general meeting of May 12, 2023

26.04.2023 - Regulatory News: ACTICOR BIOTECH (Paris:ALACT) (FR0014005OJ5 - ALACT), a clinical-stage biotechnology company focused on the development of innovative drugs for the treatment of cardiovascular emergencies, in particular stroke, announces today the ...